Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
  |
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research
Most Accessed Articles
Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic
, 2020; 20(1): 3-18.Feng Gao* and Chun Yang
DOI: 10.2174/1568009619666191114110359
C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular Carcinoma
, 2020; 20(1): 59-66.Zhuo Xu, Shao-Hua Meng, Jian-Guo Bai, Chao Sun*, Li-Li Zhao*, Rui-Feng Tang, Zhao-Lin Yin, Jun-Wei Ji, Wei Yang and Guang-Jun Ma
DOI: 10.2174/1568009619666190912161003
Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide
, 2020; 20(2): 115-129.Md Wahiduzzaman, Akinobu Ota* and Yoshitaka Hosokawa
DOI: 10.2174/1568009619666191021122006
Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update
, 2018; 18(9): 857-868.Shirin Eyvazi, Safar Farajnia*, Siavoush Dastmalchi, Farzad Kanipour, Habib Zarredar and Mojghan Bandehpour
DOI: 10.2174/1568009618666180102102311
PPARγ Agonists in Combination Cancer Therapies
, 2020; 20(3): 197-215.Piotr Mrowka and Eliza Glodkowska-Mrowka*
DOI: 10.2174/1568009619666191209102015
Multiple Myeloma and the Immune Microenvironment
, 2017; 17(9): 806-818.Yawara Kawano, Aldo. M. Roccaro, Irene M. Ghobrial* and Jamil Azzi*
DOI: 10.2174/1568009617666170214102301
Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
, 2017; 17(9): 846-857.Shahzad Raza, Rachael A. Safyan and Suzanne Lentzsch*
DOI: 10.2174/1568009617666170214104426
Well-defined Graphene Oxide as a Potential Component in Lung Cancer Therapy
, 2020; 20(1): 47-58.Agnieszka Zuchowska, Elzbieta Jastrzebska, Marta Mazurkiewicz-Pawlicka, Artur Malolepszy, Leszek Stobinski, Maciej Trzaskowski and Zbigniew Brzozka*
DOI: 10.2174/1568009619666191021113807
Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects
, 2020; 20(3): 168-186.Tabinda Urooj*, Bushra Wasim, Shamim Mushtaq, Syed Nudrat Nawaid Shah and Muzna Shah
DOI: 10.2174/1568009620666191220151856
Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell Lymphoma
, 2019; 19(9): 681-687.Linqing Zou, Guoqi Song, Siyu Gu, Lingling Kong, Shiqi Sun, Li Yang* and William C. Cho*
DOI: 10.2174/1568009619666190126125251
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net